Publication | Open Access
Functional Characterization of the Human Placental Fusogenic Membrane Protein Syncytin 21
158
Citations
43
References
2008
Year
Protein SecretionMolecular BiologyCytoskeletonEnvelope ProteinCellular PhysiologyEmbryologySecretory PathwayPlacental DevelopmentProtein FunctionMembrane BiologySyncytin 2Embryonic DevelopmentGene ExpressionCell BiologyPlacental FunctionDevelopmental BiologySignal TransductionNatural SciencesPlacental Cell FusionFunctional CharacterizationIntracellular TraffickingCellular BiochemistryMedicine
Fusion of cytotrophoblasts into the multinucleated syncytiotrophoblast layer is essential for the development of a functional placenta. The envelope protein of a human endogenous retrovirus W (HERV-W) family member, syncytin 1, has been shown to mediate placental cell fusion. Recently, the envelope protein of another HERV family member (HERV-FRD), syncytin 2, has been identified and shown to be highly expressed in the placenta. To better understand the biology of syncytin 2, in this study we first investigated syncytin 2 gene expression in normal and preeclamptic placentas and then characterized the functions of syncytin 2. The expression of syncytin 2 gene was decreased in preeclamptic placentas and could be stimulated by the cAMP stimulant forskolin. The endoprotease furin was found to be involved in the posttranslational cleavage of syncytin 1 and 2 polypeptides into surface and transmembrane subunits. In addition, proper association of the subunits of syncytins 1 and 2 is probably required for the functional integrity of each protein, because subunit swapping of syncytins 1 and 2 failed to generate fusogenic chimeras. Finally, we demonstrated that the disulfide bridge-forming CX(2)C and CX(7)C motifs found in syncytins 1 and 2 are essential for their fusogenic activities, because mutations in the CX(2)C motif not only abolished fusogenesis but also functioned as dominant-negative mutants. Our results suggest that syncytin 2 may function as a second fusogenic protein for placental cell fusion.
| Year | Citations | |
|---|---|---|
2001 | 24.3K | |
1991 | 4K | |
2000 | 3.3K | |
2000 | 1.6K | |
1994 | 932 | |
2000 | 702 | |
2003 | 531 | |
A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Carl Wild, Terrence G. Oas, Charlene McDanal, Proceedings of the National Academy of Sciences ImmunologyMolecular BiologySynthetic Peptide InhibitorPeptide SciencePeptide Therapeutics | 1992 | 486 |
2003 | 423 | |
2004 | 381 |
Page 1
Page 1